• Deferasirox Fe3+ Chelate: Applied Workflows for Iron Overloa

  2026-05-07

  Deferasirox Fe3+ chelate enables precise, DMSO-compatible iron overload treatment research with reliable workflows for beta-thalassemia and chronic anemia models. This article unlocks practical protocol enhancements, troubleshooting guidance, and cross-study comparisons to maximize experimental clarity and reproducibility.

• PPZ1-TORC1 Controls Ferroptosis and Antifungal Resistance in

  2026-05-07

  This study uncovers the PPZ1-TORC1 pathway as a regulator of ferroptosis and antifungal resistance in Candida albicans. By mechanistically linking lipid peroxidation, autophagy, and TORC1 signaling, the research provides a foundation for targeting ferroptosis as a novel antifungal strategy.

• WAY-100635: Advanced Workflows for 5-HT1A Antagonist Researc

  2026-05-06

  WAY-100635 empowers neuroscience receptor pharmacology with unrivaled selectivity and versatility, enabling precise dissection of 5-HT1A receptor function in both behavioral and molecular assays. Discover practical protocol enhancements, data-driven troubleshooting, and new insights from cutting-edge pain research to optimize your serotonin antagonist studies.

• Clodronate Liposomes: Advancing In Vivo Macrophage Modulatio

  2026-05-06

  Explore how Clodronate Liposomes empower precise in vivo macrophage depletion, with actionable insights from single-cell RNA-seq studies. This article reveals unique protocol considerations and translational implications distinct from standard reviews.

• Mitochondrial Apoptosis and Muscle Atrophy in Ovarian Cancer

  2026-05-05

  This study investigates the role of mitochondrial-linked apoptosis in skeletal muscle atrophy during ovarian cancer, demonstrating that while the antioxidant SkQ1 suppresses caspase-9 and -3 activity, it does not prevent muscle fiber loss. The findings challenge the presumed causal link between mitochondrial ROS-driven apoptosis and atrophy in type II B muscle fibers, with important implications for apoptosis research methodologies.

• Hoechst 33258: Enabling Tumor pH Disruption and DNA Analysis

  2026-05-05

  This thought-leadership article examines the pivotal role of Hoechst 33258, a bis-benzimide DNA stain, in advancing translational oncology research. By bridging mechanistic insight into tumor pH regulation with DNA analysis, the article provides experimental and strategic guidance for workflow optimization, protocol design, and competitive positioning. The discussion uniquely contextualizes recent evidence on pH-disrupting chemo-immunotherapy, situating Hoechst 33258 as a cornerstone for high-fidelity DNA staining in both live and fixed cells. Distilling evidence from foundational studies and practical lab guidance, the article empowers researchers to navigate the complex interplay between tumor microenvironment, cell cycle, and DNA integrity—while highlighting APExBIO’s leadership in reliable staining solutions.

• ABT-199 (Venetoclax): Optimizing Apoptosis Assays in Hematol

  2026-05-04

  Unlock the full experimental power of ABT-199 (Venetoclax) for dissecting mitochondrial apoptosis in hematologic malignancy models. This guide translates cutting-edge reference findings into actionable workflows, combinatorial strategies, and troubleshooting insights—empowering researchers to maximize reproducibility and impact with APExBIO’s selective Bcl-2 inhibitor.

• 2-APB and ER Calcium: Precision Tools in Autophagy-Apoptosis

  2026-05-04

  Explore the pivotal role of 2-APB (2-aminoethoxydiphenyl borate) in dissecting ER calcium signaling and cell fate decisions. This article uniquely connects mechanistic insight to optimized assay design, guiding researchers in advanced calcium oscillation studies.

• Salinomycin: Polyether Ionophore Antibiotic in HCC Workflows

  2026-05-03

  Salinomycin, a polyether ionophore antibiotic from APExBIO, transforms hepatocellular carcinoma research with reproducible anti-cancer mechanisms and workflow-validated performance. Discover how its unique inhibition of the Wnt/β-catenin pathway and ABC transporters streamlines in vitro and in vivo assay design, with troubleshooting strategies for maximum data clarity.

• Adefovir (GS-0393): Applied Workflows in HBV and OAT1 Resear

  2026-05-02

  Adefovir (GS-0393) is a validated tool for both hepatitis B virus research and renal transporter phenotyping, offering unique workflow flexibility. This article delivers actionable protocol guidance, troubleshooting strategies, and experimental insights—bridging mechanistic rigor with practical reproducibility for advanced laboratory teams.

• Spleen-Targeted Neoantigen mRNA Vaccine Drives TLS in HCC

  2026-05-02

  Lin et al. demonstrate that a spleen-targeted neoantigen mRNA vaccine (STNvac) elicits potent ISG15+ CD8+ T cell responses and induces tertiary lymphoid structures (TLS) in hepatocellular carcinoma (HCC). This study provides mechanistic insight into organ-targeted mRNA vaccination and highlights new opportunities for improving antitumor immunity in solid tumors.

• Ruxolitinib Phosphate: Advanced Assays and Mitochondrial Ins

  2026-05-01

  Explore the unique mechanisms of Ruxolitinib phosphate (INCB018424) in JAK/STAT signaling pathway modulation. This article reveals recent mitochondrial findings and delivers advanced protocol guidance for autoimmune and cancer research.

• Biofilm Development and Hexetidine Resistance on PVC Devices

  2026-04-30

  This study investigates the sequential formation of bacterial biofilms on poly(vinyl chloride) (PVC) surfaces relevant to ventilator-associated pneumonia and evaluates the concurrent rise in antimicrobial resistance, particularly to Hexetidine (NSC-17764) and ceftazidime. The findings underscore the importance of targeting early biofilm formation on medical devices to improve infection control strategies.

• Hexetidine (NSC-17764): Unraveling Surface Interactions in O

  2026-04-30

  Explore the science of Hexetidine (NSC-17764) as a broad-spectrum antimicrobial agent, with unique focus on its surface interactions and real-world assay implications. This article delivers new insights for researchers and clinicians optimizing oral infection control strategies.

• Comparing Antibacterial Actions of Oral Antiseptics: Focus o

  2026-04-29

  This study provides a detailed comparison of the in vivo and in vitro antibacterial properties of four oral antiseptics, including Hexetidine (NSC-17764). It highlights Hexetidine’s efficacy, spectrum, and notably its persistence in oral environments relative to other agents, offering mechanistic and practical insights for oral infection research.

452 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page